GPW
GILD icon

Genesis Private Wealth’s Gilead Sciences GILD Stock Holding History

Genesis Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Sell
3,364
-149
-4% -$19.6K 0.12% 98
2026
Q1 		$490K Sell
3,513
-497
-12% -$69.6K 0.15% 87
2025
Q4 		$492K Buy
4,010
+2,168
+118% +$263K 0.15% 89
2025
Q3 		$205K Sell
1,842
-439
-19% -$49.9K 0.09% 151
2025
Q2 		$253K Sell
2,281
-840
-27% -$89.4K 0.12% 117
2025
Q1 		$350K Sell
3,121
-794
-20% -$81.9K 0.19% 69
2024
Q4 		$362K Buy
+3,915
New +$352K 0.2% 62

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Genesis Private Wealth's GILD Position: Q2 2026 in Review

Genesis Private Wealth reduced its Gilead Sciences (GILD) stake by 4.2% in Q2 2026, selling an estimated $19.6K and leaving 3,364 shares worth $425K. The position accounts for 0.12% of the portfolio, ranked #98.

Genesis Private Wealth first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $492K in Q4 2025. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Genesis Private Wealth held 3,364 shares of Gilead Sciences worth $425K as of Q2 2026.
  • Genesis Private Wealth sold 149 Gilead Sciences shares in Q2 2026, an estimated $19.6K.
  • Gilead Sciences made up 0.12% of Genesis Private Wealth's portfolio in Q2 2026, its #98 holding.
  • Genesis Private Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Genesis Private Wealth's Gilead Sciences position peaked at $492K in Q4 2025.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.